CBAY - Cymabay Therapeutics Inc. (CBAY) CEO Sujal Shah on Q4 2020 Results - Earnings Call Transcript

Cymabay Therapeutics, Inc. (CBAY) Q4 2020 Earnings Conference Call March 25, 2021, 16:30 ET Company Participants Daniel Menold - VP, Finance Sujal Shah - President, CEO & Director Charles McWherter - SVP & Chief Scientific Officer Klara Dickinson - Chief Regulatory & Quality Assurance Officer Conference Call Participants Yasmeen Rahimi - Piper Sandler & Co. Steven Seedhouse - Raymond James & Associates Patrick Dolezal - LifeSci Capital Jay Olson - Oppenheimer Thomas Smith - SVB Leerink Mayank Mamtani - B. Riley Securities Ed Arce - H.C. Wainwright & Co. Presentation Operator Good day, ladies and gentlemen, and welcome to CymaBay's Fourth Quarter and Full Year 2020 Financial Results and Business Update Conference Call. [Operator Instructions]. Please be advised that the call will be recorded at the company's request. It is also being webcast live on the Investors section at the CymaBay website at www.cymabay.com. Now I would like to turn

For further details see:

Cymabay Therapeutics, Inc. (CBAY) CEO Sujal Shah on Q4 2020 Results - Earnings Call Transcript